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Abstract
Background: Missing data is classified as missing completely at random (MCAR), missing at
random (MAR) or missing not at random (MNAR). Knowing the mechanism is useful in identifying
the most appropriate analysis. The first aim was to compare different methods for identifying this
missing data mechanism to determine if they gave consistent conclusions. Secondly, to investigate
whether the reminder-response data can be utilised to help identify the missing data mechanism.
Methods: Five clinical trial datasets that employed a reminder system at follow-up were used.
Some quality of life questionnaires were initially missing, but later recovered through reminders.
Four methods of determining the missing data mechanism were applied. Two response data
scenarios were considered. Firstly, immediate data only; secondly, all observed responses
(including reminder-response).
Results: In three of five trials the hypothesis tests found evidence against the MCAR assumption.
Logistic regression suggested MAR, but was able to use the reminder-collected data to highlight
potential MNAR data in two trials.
Conclusion: The four methods were consistent in determining the missingness mechanism. One
hypothesis test was preferred as it is applicable with intermittent missingness. Some inconsistencies
between the two data scenarios were found. Ignoring the reminder data could potentially give a
distorted view of the missingness mechanism. Utilising reminder data allowed the possibility of
MNAR to be considered.
Background
Missing data are a major issue during the analysis of any
study. The absence of data can be informative, and should
not be disregarded; ignoring the pattern of missingness
may bias the results obtained. In particular, for health-
related quality of life (QoL) outcomes, the fact that data
are missing may be informative. Patients who feel unwell
are perhaps likely to be less able to complete and return
questionnaires.
Patterns of missingness are described as either monotone
(terminal), intermittent or mixed. Monotone missingness
occurs when data are available at every assessment until a
time the patient drops out and provides no further assess-
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ments. Intermittent missingness occurs if there is a miss-
ing observation in between observed assessments. A
mixed pattern occurs when a period of intermittent miss-
ingness is followed by monotone missingness. The three
mechanisms of missing data are missing completely at
random (MCAR), missing at random (MAR) and missing
not at random (MNAR) [1]. Determining the mechanism
helps to identify the most appropriate analysis method.
Complete-case analysis (excluding patients who have
incomplete data) will only be unbiased (although not
optimal) if the data are MCAR. Under MAR, available case
analysis such as mixed effects models can be used whereas
for MNAR data fewer, more sophisticated methods are
appropriate [2].
The Centre for Healthcare Randomised Trials at the Univer-
sity of Aberdeen routinely employs a reminder system when
administering follow-up questionnaires. When a patient
does not respond within two weeks of the initial mailing, a
reminder questionnaire is sent and a second, two weeks later
when required. At each assessment there are three types of
responder: immediate-responders (no reminder necessary),
reminder-responders (responded following one or more
reminders), and non-responders. We aim to determine if the
reminder-response data can be utilised to identify the non-
response mechanism. We compare the missingness mecha-
nism when the reminder-response data is included (that is
using all available data) and excluded (as they would be in
those clinical trials that do not employ a reminder system).
Four different methods to identify the missingness mecha-
nism were applied and contrasted.
Methods
Datasets
Datasets from five clinical trials that administered the
EuroQoL EQ5D [3] instrument were used. The EQ5D is a
generic QoL questionnaire, with five questions covering:
mobility, self-care, usual activities, pain/discomfort and
anxiety/depression. Each question has a three-category
response scale, with a single index generated for all health
states, using the EuroQoL UK population tariff. This gen-
erates 3 × 3 × 3 × 3 × 3 = 243 unique values ranging from
-0.59 (worst QoL) to 1 (best QoL). The EQ5D score is usu-
ally treated as a continuous variable. The five trials are:
1. REFLUX (N = 357) – evaluating the clinical- and cost-
effectiveness of early laparoscopic surgery compared with
continued medical management amongst people with
gastro-oesophageal reflux disease. QoL data was collected
at baseline, three and twelve months after surgery, and at
equivalent times for those medically managed [4].
2. MAVIS (N = 910) – RCT of multi-vitamin and mineral
supplementation in persons aged 65 and over, to reduce
infection rates and antibiotic usage. QoL data was col-
lected at baseline, six and twelve months follow-up [5].
3. RECORD (N = 5292) – a placebo-controlled trial of
daily oral vitamin D and calcium in the secondary preven-
tion of osteoporosis-related fractures in older people. QoL
was assessed at four months (baseline) and then yearly up
to four years [6].
4. KAT – overlapping trials measuring clinical and cost
effectiveness of different types of knee replacement. The
comparison presented evaluates the benefits of patella
resurfacing during knee replacement (N = 1517). QoL was
measured at baseline, three months and annually after the
operation [7].
5. PRISM (N = 1324) – evaluating the clinical- and cost-
effectiveness of symptomatic versus intensive biphospho-
nate therapy for the management of Paget's disease. QoL
was assessed at baseline and then annually [8].
Each dataset contained a proportion of patients with com-
plete data or a monotone, intermittent or mixed missing
data pattern.
Mechanisms of missing data
The missing data 'mechanism' relates to the underlying rea-
son why the data are missing. Rubin [1] presents the stand-
ard definition of the missing data mechanism which can be
classified as MCAR, MAR or MNAR (see Appendix for formal
definition). In summary, MCAR depends on observed cov-
ariates, but not on the observed or unobserved outcomes.
The MAR mechanism depends on the observed outcomes
and perhaps covariates, but not further on unobserved meas-
urements. MNAR does depend on unobserved measure-
ments, perhaps in addition to covariates and/or observed
outcomes [9]. MCAR and MAR are often referred to as ignor-
able – that is if a dropout process is random then unbiased
estimates can be obtained from likelihood-based estimation
[2,10]. MNAR is non-ignorable, because to do so would lead
to biased results.
In the context of QoL, MCAR occurs if the missingness has
nothing to do with QoL status. For example, the form may
be missing because it got lost in the post. MCAR includes
'covariate dependent missingness' – for example, if miss-
ingness varies between age groups, but within each age
group, missingness is MCAR. When missingness is related
to the observed QoL scores, we have MAR data. MNAR
describes missingness that is related to unobserved QoL. An
example would be missing values arising because severely
ill patients felt too weak to complete questionnaires.
Methods for determining the mechanism of missingness
There are a number of hypothesis tests that can be carried
out to test for MCAR. Little [11] developed a test based on
means under the different missing data patterns. Listing
and Schlittgen also proposed a test based on means [12]
and secondly a non-parametric procedure which com-Health and Quality of Life Outcomes 2009, 7:57 http://www.hqlo.com/content/7/1/57
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bines several Wilcoxon rank sum tests [13]. Schmitz and
Franz discussed a non-parametric version of the first List-
ing and Schlittgen test [14]. Diggle [15] used an approach
which tests whether the subset about to dropout are a ran-
dom sample of the whole population. Ridout [16]
adopted a similar approach to Diggle, by utilising logistic
regression. Fairclough [2] detailed a logistic regression
procedure subtly different from that of Ridout.
The missing data patterns displayed by the example data-
sets are a mixture of monotone, intermittent and mixed.
Of the hypothesis tests described, only Little's test can be
applied to datasets containing intermittent and mixed
patterns in addition to monotone patterns. The remaining
hypothesis tests are restricted to monotone missingness.
Therefore, Little's test [11] was chosen to be applied and
despite requiring monotone missingness Listing and
Schlittgen's parametric test [12] was chosen as a compari-
son. Both Ridout and Fairclough logistic regression were
employed.
Little's test [11] and the Listing and Schlittgen test [12]
provide a global view of the missingness mechanism. Fair-
clough's method [2] is similar to that of Ridout [16] but
in Ridout's approach the indicator of missingness is
between responders at a given assessment who continue
in the study and those who do not. Fairclough's [2] miss-
ingness indicator distinguishes between responders and
non-responders at each assessment. No restriction to the
data is required for either logistic regression procedure.
The mathematical details of these methods are found in
the Appendix but are now described in non-technical lan-
guage.
Little's test of MCAR
This test is based on the premise that under MCAR at each
assessment the calculated means of the observed data
should be the same irrespective of the pattern of missing-
ness [11]. The null hypothesis is that the data are MCAR.
If the data are not MCAR, the mean scores at each assess-
ment will vary across the patterns.
Listing and Schlittgen (LS) test: to determine if dropouts are missed 
at random
Listing and Schlittgen [12] proposed a test (denoted the
'LS test') to determine if 'dropouts' occurred at random.
This test requires a monotone missing data pattern and
the null hypothesis is that the dropouts are missed at ran-
dom. At each assessment a test is based on the difference
in the mean of the values of the individuals who continue
to stay in the study and the mean for those individuals
who drop out after this time. The test statistic combines
the weighted differences of the means of dropouts and
non-dropouts at the different assessments (see Appendix).
For the non-dropouts only the patients providing all
assessments are used. This ensures that a possible contin-
uing slow change in the means of later dropouts does not
mask the differences of mean values by moving the mean
of the non-dropouts into the direction of the mean of the
dropouts.
Ridout's logistic regression method
Diggle [15] proposed a method of testing the hypothesis
that dropouts occur at random within treatment groups
against the alternative hypothesis that their occurrence is
related to a particular covariate. Following this, Ridout
proposed a comparable test for random dropouts in
repeated measurement data using logistic regression [16].
At each assessment, one identifies the set of patients for
whom assessment is available at that point and then iden-
tifies the subset for which this is the final assessment
before they drop out of the study. The test for MCAR, tests
the assumption that scores from the subset of subsequent
dropouts are a random sample from all those providing
assessment. The response variable is 'dropout or not at a
particular assessment' in the standard logistic regression
model [17]. It is possible under MCAR that dropout may
depend on fixed covariates (covariate-dependent drop-
out).
Fairclough's logistic regression method
Fairclough outlined an approach to identify the missing-
ness mechanism using logistic regression [2]. The first step
is to identify any variables within the dataset that are asso-
ciated with the indicator of missingness (response or not
at a particular assessment). These could include demo-
graphic variables or other treatment related variables. A
logistic model can be created from the significant candi-
date variables, using a stepwise procedure. Differences
between MCAR and MAR can be assessed by examining
the association of missing data with observed QoL scores,
using logistic regression. To confirm that missingness
depends on observed data after adjusting for the depend-
ence on any covariates, the covariates are forced into the
model and the observed QoL is tested for inclusion. If the
observed QoL score is significant in the model predicting
missingness then there is evidence of MAR data.
Comparison of immediate and reminder responders using 
Fairclough's method
By restricting the dataset to responders only and regarding
the reminder-response as missing, Fairclough's logistic
regression approach can be used to determine whether
reminder-data are MNAR rather than MCAR or MAR. If
the current QoL score is significant in the logistic model
having adjusted for covariates and previously observed
QoL, then there is evidence of possible MNAR data. This
conclusion is only possible because we are using all
responder data and the true value of the data which we are
regarding as missing (in the indicator variable) is known.Health and Quality of Life Outcomes 2009, 7:57 http://www.hqlo.com/content/7/1/57
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Overview
To undertake the LS test restricted trial datasets using only
those patients with a monotone missingness pattern were
created. The four methods to determine the missingness
mechanism were applied. Scenario one contains the
immediate response data versus the missing data
(reminder-response or actual non-responders). Scenario
two includes response data (immediate and reminder
responders) and investigates the mechanism behind non-
response.
In addition, a subset of data which included only
responders at each assessment was created. The responses
received after reminders were set to missing and the mech-
anism behind reminder-response investigated. Fairclough
logistic regression was used to determine whether the cur-
rent score was a predictor of reminder-response, suggest-
ing MNAR. With the rationale that reminder-responders
are perhaps closer to the non-responders, if reminder-
response is MNAR it implies that non-response is likely
MNAR. Previous QoL is defined to be the last known QoL
score. All analysis was undertaken in STATA/SE version
10.1 for Windows.
Results
Table 1 shows the proportions of responders in each
response category. MAVIS had an excellent response rate
to the initial mailing, while REFLUX showed the poorest
initial response rate. The reminder system generated a sig-
nificant amount of data producing an overall response
rate of 86% at three months and 89% at 12 months.
RECORD showed the poorest overall response rate (22%–
35% non-responders). The reminder system did generate
about a quarter of all responses.
Table 2 displays the baseline QoL scores split by
responder type at the first follow up. In each of the five tri-
als, the participants who responded immediately at first
follow-up had better baseline QoL scores than those who
were reminder-responders or non-responders. This pat-
tern was particularly evident in REFLUX, MAVIS and
RECORD. This suggests those patients who were display-
ing poorer baseline QoL were more likely to be a
reminder-responders or non-responder at follow up, indi-
cating a MAR mechanism. The four methods to determine
the mechanism of missingness were used to confirm this
hypothesis. Scenario one utilised the immediate
responses and regarded reminder responders along with
the true non-responders as missing. Scenario two
included the reminder-response values in the responder
set and missing data was only that arising from non-
response.
Hypothesis tests for mechanism of missingness
Table 3 shows the results of Little's hypothesis test of
MCAR. In general there was evidence against MCAR,
except for the MAVIS trial in scenario one and the PRISM
trial in scenario two, where missingness was MCAR (cov-
ariate-dependent). The mechanism was consistent
between these two scenarios except for the two cases
above. In MAVIS scenario one was found to be MCAR
while scenario two was not MCAR. Conversely in PRISM
scenario one was not MCAR while there was no evidence
against MCAR for scenario two.
Table 4 shows the results of the LS test applied to the
restricted dataset containing only those patients with a
monotone missing data pattern. The majority of patients
in MAVIS had monotone missingness with 80% in sce-
nario one and 89% in scenario two. RECORD had only
45% and 69% displaying monotone missingness in sce-
nario one and two respectively. The LS Test generally
found evidence against MCAR except for the REFLUX trial,
where scenario two was found to be MCAR. As with Lit-
tle's test, apart from this situation, the conclusion against
MCAR occurred for both scenario one and two. Bearing in
Table 1: Percentage of each type of responder in each trial
Type of responder
Trial Assessment Immediate Reminder Non-responder
REFLUX (N = 357) 3 months 39 47 14
12 months 38 51 11
MAVIS (N = 910) 6 months 91 4 5
12 months 81 11 8
RECORD (N = 5292) 4 months 58 20 22
12 months 54 17 29
24 months 51 14 35
KAT (N = 2356) 3 months 79 9 12
1 year 74 13 13
2 years 69 15 16
PRISM (N = 1324) 1 year 85 6 9
2 years 63 14 23Health and Quality of Life Outcomes 2009, 7:57 http://www.hqlo.com/content/7/1/57
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mind, the LS test is only applicable for monotone missing
data, the two methods usually provided the same conclu-
sion; that is, there was evidence against MCAR suggesting
missingness was MAR or possibly MNAR.
Ridout Logistic regression for the missingness mechanism
The first stage was to identify those baseline covariates
which were associated with dropout after a particular
assessment. All adjusted OR's were less than one implying
that those with better QoL at the current assessment were
less likely to drop out (data not shown). Table 5 shows the
findings from the Ridout logistic regression procedure at
each assessment.
RECORD, KAT and PRISM provided consistent conclu-
sions between scenario one and two. Missing data in
RECORD and PRISM were found to be MAR, while in KAT
data were MCAR at baseline, but MAR at three and 12
months follow up. Some inconsistencies were shown for
REFLUX and MAVIS. In REFLUX, ignoring the reminder-
response at baseline (scenario one) indicated data were
MAR, but including the reminder-response data (scenario
two) suggested MCAR. Data were MAR at three months in
both scenario one and two. MAVIS data was found to be
MCAR at baseline, but scenario one found MCAR data at
six months, while scenario two suggested MAR data.
Fairclough Logistic regression for the missingness 
mechanism
Firstly the covariates associated with missingness at each
assessment were identified and the inclusion of previous
QoL was assessed (data not shown). Table 5 shows the
findings from Fairclough logistic regression. RECORD
and PRISM data were found to be MAR at each assessment
for each of the two scenarios. KAT generally displayed
MAR except in scenario two where data was MCAR.
Table 2: Baseline QoL scores split by responder type at first follow-up
Immediate responders Reminder responders Non-responders
Mean (SD) Mean (SD) Mean (SD)
REFLUX EQ5D 0.75 (0.21) 0.70 (0.25) 0.70 (0.23)
(3 m) Physical summary 45.2 (9.5) 44.9 (9.5) 45.5 (9.0)
Mental Summary 47.3 (11.2) 44.5 (11.3) 42.1 (14.7)
RQLS 66.8 (25.0) 64.3 (24.0) 64.0 (24.2)
MAVIS EQ5D 0.77 (0.21) 0.73 (0.23) 0.70 (0.23)
(6 M) Physical summary 43.6 (11.0) 40.9 (10.4) 40.0 (11.0)
Mental Summary 53.9 (8.6) 51.7 (9.9) 52.2 (9.1)
RECORD EQ5D 0.74 (0.23) 0.69 (0.25) 0.66 (0.29)
(12 m) Physical summary 41.7 (10.7) 40.0 (11.1) 38.6 (11.8)
Mental Summary 51.7 (9.9) 48.8 (10.3) 47.3 (11.4)
KAT EQ5D 0.39 (0.31) 0.34 (0.31) 0.35 (0.32)
(3 m) Physical summary 31.1 (8.2) 30.0 (8.7) 31.5 (8.3)
Mental Summary 50.1 (11.4) 50.2 (11.8) 47.1 (12.0)
Oxford Knee Score 18.2 (7.5) 17.0 (7.6) 17.5 (8.2)
PRISM EQ5D 0.59 (0.30) 0.63 (0.27) 0.43 (0.34)
(12 m) Physical summary 36.5 (11.4) 37.4 (10.9) 33.2 (10.0)
Mental Summary 48.9 (11.8) 48.0 (11.8) 46.8 (12.1)
Arthritis Index 36.1 (12.7) 36.1 (12.6) 31.9 (11.0)
Table 3: Results of Little's test
Scenario 1 Scenario 2
LITTLES TEST Test Statistic (p-value) MCAR? Test Statistic (p-value) MCAR?
REFLUX 18.6 (p = 0.01) not MCAR 21.5 (p = 0.011) not MCAR
MAVIS 11.1 (p = 0.20) MCAR 19.0 (p = 0.015) not MCAR
RECORD 108.2 (p < 0.001) not MCAR 133.8 (p < 0.001) not MCAR
KAT 91.6 (p < 0.001) not MCAR 89.0 (p < 0.001) not MCAR
PRISM 26.9 (p = 0.001) not MCAR 14.0 (p = 0.12) MCARHealth and Quality of Life Outcomes 2009, 7:57 http://www.hqlo.com/content/7/1/57
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REFLUX data was found to be MCAR except in scenario
one where MAR was found. In MAVIS at six months data
were MAR in scenario one but MCAR in scenario two. At
12 months, the inclusion of previous QoL was borderline
significant so there was insufficient evidence to conclude
MCAR or MAR. Scenario two found the data to be MAR.
Comparison of immediate and reminder responders using 
Fairclough's method
In this section, only those responding were considered.
The responses received via reminders were set to missing.
The advantage is that although reminder-responses were
regarded as missing, the actual QoL score was known.
Using this approach there was no indication of MNAR for
REFLUX, MAVIS and PRISM. In RECORD and KAT how-
ever, there was some indication that reminder-response
was MNAR since the QoL observed at the particular assess-
ment was found to be a predictor of missingness
(reminder-response). Therefore with the assumption that
reminder responders are similar to the non-responders,
perhaps non-response was also MNAR. This however can-
not ever be tested as the data required are missing.
Discussion
All four methods gave reasonably consistent conclusions
for the missingness mechanism within a trial. The two
hypothesis tests gave an idea of the global mechanism,
while the two logistic regression procedures looked specif-
ically at a particular assessment. The choice between
which method should be used should be determined by
what is of interest. If the overall mechanism of missing
data is of interest then Little's test should be used. This is
because this global hypothesis test allows for both mono-
tone and intermittent missing data while the LS test
requires monotone missingness. Any inconsistencies
between the two methods were mainly due to the fact that
Table 4: Results of the Listing and Schlittgen (LS) test
Scenario 1 Scenario 2
LS TEST N (%) Test Statistic In favour of MAR? N (%) Test Statistic In favour of MAR?
REFLUX 287 (80) 2.24 (p = 0.033) MAR 316 (89) 0.16 (p = 0.39) not MAR
MAVIS 881 (97) 2.79 (p = 0.008) MAR 904 (99) 4.02 (p < 0.001) MAR
RECORD 2401 (45) 10.8 (p < 0.001) MAR 3634 (69) 12.6 (p < 0.001) MAR
KAT 1771 (75) 4.45 (p < 0.001) MAR 1983 (84) 5.23 (p < 0.001) MAR
PRISM 1103 (83) 7.21 (p < 0.001) MAR 1118 (84) 5.86 (p < 0.001) MAR
Table 5: Result of Ridout and Fairclough logistic regression
Ridout regression Fairclough logistic regression
Scenario 1 Scenario 2 Scenario 1 Scenario 2
Trial Assessment Mechanism Mechanism Mechanism Mechanism
REFLUX Baseline MAR MCAR - -
3 months MCAR MCAR MCAR MCAR
12 months - - MAR MAR
MAVIS Baseline MCAR MCAR - -
6 months MCAR MAR MAR MAR
12 months - - MCAR/MAR MCAR/MAR
RECORD 4 months MAR MAR - -
12 months MAR MAR MAR MAR
24 months - - MAR MAR
KAT Baseline MCAR MCAR - -
3 months MAR MAR MAR MAR
12 months MAR MAR MAR MAR
24 months - - MAR MAR
PRISM Baseline MAR MAR - -
12 months MAR MAR MAR MAR
24 months - - MAR MARHealth and Quality of Life Outcomes 2009, 7:57 http://www.hqlo.com/content/7/1/57
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the LS test used a subset of the data as not all patients
showed a monotone missing data pattern.
If the missing data mechanism at a particular assessment
is of interest then either Fairclough's method or Ridout
logistic regression can be used. The choice between the
two is dependent on which binary indicator is of most rel-
evance. Fairclough distinguishes between missing or not
at a particular assessment. Ridout takes responders at a
particular assessment and investigates whether they con-
tinue and provide a further assessment or whether this is
their last assessment and they drop out. Although very
similar procedures, the outcome variable is subtly differ-
ent. The situation that is of most relevance to the
researcher drives the choice between the two methods.
The mechanism was not always the same in scenario one
and two suggesting the reminder data has an important
role to play. In a trial which does not employ a reminder
system, only the immediate-responses would be available.
If the investigation into the missingness mechanism was
based on only this data, then one could potentially get a
distorted view. This highlighted that the reminder-
responses have an important role to play, not only to
increase sample size but to ensure the conclusion on the
missing data mechanism is the correct one, to inform the
most appropriate analysis strategy. Obtaining as much
data as possible is always going to give a more informed
decision and ultimately reduce any potential bias in anal-
ysis results.
The mechanism of missing data within a particular trial
did differ at different assessments using Ridout of Fair-
clough logistic regression. For example in REFLUX sce-
nario one, there was evidence of MAR after baseline but
MCAR after three months using Ridout logistic regression.
This difference is likely to be caused by the much smaller
amount of missing data and the number of patients with
each missing data pattern and particularly the number
dropping out after the assessment. At three months of
those who provided the assessment (N = 302) only 12
dropped out and thus possibly one reason why there was
no evidence against the MCAR assumption. In the larger
trials the mechanism of missing data was much more con-
sistent across assessments.
In three of the five trials there was evidence against MCAR
data. The advantage of Little's test over the LS test is that it
can be applied under any missing data pattern, not just
monotone. Intermittent missingness occurred in all five
trials and therefore the results of Little's test are more reli-
able. For two trials, current QoL was impacting on
reminder-response and thus there was potentially MNAR
data. Usually this conclusion is not possible, and MAR
cannot be distinguished from MNAR, as the data required
are missing.
It is possible that once patients know they will receive a
reminder they may delay response until the reminder is
received. The participants would probably not know this
until they received their first reminder but at subsequent
assessment it would be known. Conversely, once it is
known reminders will be sent, this may prompt partici-
pants to respond early to avoid being sent the reminder. It
was not possible to distinguish the reasons for repeated
reminder response or not and it may be part of the partic-
ipants personality. Some may just be slow-responders and
need the reminder to prompt response. In the trials used
here the proportion of participants who repeatedly
responded by reminder is minimal. In the trials used here
the 'learning-effect' of reminders did not appear to be a
factor, but it would be interesting to investigate this in
future work, as some would argue that only an unexpected
reminder is close to the missing data situation.
The sensitivity of different analyses depends on the pro-
portion of missing assessments and the strength of the
underlying causes for missing data [18]. In general the
undesirable effect of missingness on bias and power
increases with the severity of non-randomness as well as
the proportion of missingness [19]. It is crucial to identify
the mechanism of missingness and thus the most appro-
priate method for valid analysis and minimum biased
results. In the unlikely situation that data can be con-
firmed as being MCAR, complete case analysis or simple
methods of imputation could be used. In the more likely
situation of MAR data, multiple imputation is useful [20].
An alternative would be available case analysis and in the
longitudinal setting a repeated measures model would be
appropriate. When data is thought likely to be MNAR,
more sophisticated approaches such as joint modelling or
pattern mixtures models should be used [2]. Previously it
has been shown that in the presence of MNAR, simple
imputation methods were not adequate and perhaps mul-
tiple imputation was more suitable [21]. An extension to
this work is ongoing where appropriate imputation meth-
ods or model-based procedures can be identified for use
when the data is known to have a particular mechanism
of missingness.
Strengths and limitations
The main strength of this study was the ability to makes
use of reminder data to investigate the missing data mech-
anism. Previous work has simulated missing data subject
to a known mechanism whereas we have used real data to
test procedures. The variety of datasets allowed the proce-
dures to be investigated for different proportions of miss-
ing data and for different missing data patterns.Health and Quality of Life Outcomes 2009, 7:57 http://www.hqlo.com/content/7/1/57
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Each of the trial datasets employed at least one further
QoL measure and the same process as presented above
was implemented. Similar findings occurred, suggesting
that the results are generalisable to the wider QoL research
area and not just to those studies employing the EQ5D
measure. The studies themselves were from a wide range
of disease areas – surgery for gastro-oesophageal reflux;
dietary supplementation for infections in elderly; vita-
mins and calcium for osteoporosis-related fractures; knee
replacement surgery; therapy for Paget's disease. However,
these were all trials involving patients with chronic dis-
eases, and the trials used infrequent follow-up (three or
more months between assessments). Despite this limita-
tion, we believe that the results should be generalisable to
other disease areas, and that the issues surrounding miss-
ing data in QoL are the same irrespective of the QoL meas-
ure being used. If the data are missing because reduced
QoL leads to informative censoring, then this should be
taken into consideration in any analysis.
One point to note throughout this work is that data col-
lected via reminder has equal footing to that which was
obtained immediately. In the EQ5D instrument the ques-
tions refer to health state 'today'. It is possible that filling
in questionnaires after reminder may be associated with a
certain amount of bias as 'today' has been shifted on in
time by a couple of weeks. This is more of an issue if data
is being collected at more frequent intervals for example
monthly rather than annually, or if it is likely that
patients' conditions are changing over the time period
because of disease progression or consequences of treat-
ment. In these trials follow up was on at least three or six
monthly intervals and therefore this issue was not consid-
ered a problem for these studies but would be worth con-
sidering in the future.
Conclusion
We recommend that where possible the reminder data
should be collected as it has an important role to play.
Records should be kept of which responses were received
by reminder and then investigators can make use of the
data in the ways we have illustrated. Little's test is applica-
ble for all missing data patterns and therefore is the rec-
ommended hypothesis test of MCAR. To obtain a more
detailed investigation into the missingness mechanism at
a particular assessment, a logistic regression procedure is
useful. Deciding between Ridout and Fairclough's
approaches would depend on whether the mechanism
behind current dropout (Fairclough) or dropout after the
assessment in question (Ridout) is of most interest; the
choice remains with the researcher.
The methods outlined in this paper are generalisable to
any outcome collected by postal questionnaire and not
just QoL. The implications for research are that the system
of reminders is a useful tool in increasing the response
rate of follow-up questionnaires. The data also provide a
basis on which an investigation into the missing data
mechanism can be undertaken to help inform the most
appropriate analysis strategy.
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Appendix: Detail of the methods to identify the 
missingness mechanism
Notation
This section details the notation to be used throughout
the description of the missing data mechanism and meth-
ods to determine this mechanism. Consider a study with J
measurements of the outcome (e.g. QoL score). The com-
plete data Y is defined as
Y = (yij) where yij is the value of variable Yj for subject i. The
matrix R defines the pattern of missing data or "missing-
ness" and is defined as R = (rij) where rij = 0 if yij is missing
and rij = 1 if yij is observed. It follows that Ri is the vector of
indicators of the missing data pattern for the ith individ-
ual. Let P be the number of distinct missing data patterns
where J{p} is the number of observed variables in pattern
p. The number of cases with the pth pattern is n{p} and
. Let M{p} be a J{p} × J matrix of indicators of
the observed variables in pattern p. The matrix has one
row for each measure present consisting of (J-1) zero's and
one 1 identifying the observed measure. For example, in a
study with three assessments where the first and third
observation were obtained in the second pattern then
Lastly   is the J{p} × 1 vector of means of the observed
variables for pattern p.
Mechanism of missingness
The missing data mechanism is described by the condi-
tional distribution of R  given  Y, say f(R|Y, ),  where 
nN
p {} å =
M
2 100
001
{}=
é
ë
ê
ù
û
ú.
Y
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denotes unknown parameters. If missingness does not
depend on the values of the data Y, missing or observed
the data are MCAR; that is
Now let Yobs denote the observed components of Y and
Ymis  the missing components. For MAR, missingness
depends only on the observed components of Y and not
on the missing components, such that
MNAR occurs if the distribution of R depends on the miss-
ing values in matrix Y.
Little's test [11]
Adapting the description of Fairclough [2] the test statistic
arises as follows: the maximum likelihood (ML) estimate
of the mean of Yi is   and   is the ML estimate of the
covariance of Yi. The ML estimates assume the missing
data mechanism is ignorable and are calculated on the
available data. It follows that   is the J{p} × 1
vector of ML estimates corresponding to the pth pattern
and   is the corresponding J{p} × J{p}
covariance matrix with a correction for degrees of free-
dom. Little's proposed test statistic when Σ is unknown is,
and is asymptotically chi-squared with (Σ J{p} - J) degrees
of freedom [11].
Listing and Schlittgen test [12]
Some further notation is required for the monotone miss-
ing data pattern. Let wj indicate the number of dropouts,
at assessment j. The observation vectors yi are arranged in
a row such that the first nJ are observed at all assessments.
The next wJ-1 vectors  yi are observed at all assessments
except the last one (i.e. from time 1 to J-1). The following
wJ-2 vectors are observed at j = 1, ..., J-2 and so on. To con-
struct the overall test statistic the mean of the non-drop-
outs at a given assessment is based on the first nJ
observations, leading to
with nj = nJ + wJ-1 + ... + wJ+1 for j<J-1 and nj = nJ for j = J-1.
The statistic   with w = w1+ ... + wJ-
1.
The statistic D takes on large positive (negative) values
when all means for the dropouts are smaller (greater) than
the ones corresponding to the non-dropouts.
The test statistic   has a normal distribution
and  , but the variance
and correlations must be estimated. The correlations ρkj
are estimated from the data belonging to the non-drop-
outs only. The estimation of  2 can be based on the non-
dropouts since it is assumed that all yi have the same dis-
tribution if the null hypothesis holds.
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